“Cancer and Care” (Krebs und Fürsorge) was the theme of this year’s Asklepios Cancer Congress (Asklepios Krebskongress), which was held from 9-11 February 2023 at the Asklepios Campus Hamburg of Semmelweis University (ACH) and the St. Georg Asklepios Clinic in Hamburg. On the first day, at ACH sessions, among others things, the importance of early involvement in research and practical medical education was emphasized. These two themes are also reflected in the curriculum of Semmelweis University in Budapest.
ACH clinical training covers all fields of modern tumour medicine
The first session of ACH was chaired by Dr. Karl-J. Oldhafer, Rector’s and Dean’s Commissioner at ACH and Dr. Thorsten Thiel, Managing Director of Asklepios Medical School GmbH. Dr. András Kiss, head of the 2nd Department of Pathology at Semmelweis University, spoke first, highlighting the importance of research and patient care in the field of tumour medicine at Semmelweis University. Dr. Giorgia Schilling, medical doctor, oncologist at Asklepios Kliniken, researcher, specialist in palliative care and rheumatology, spoke about the elective course “Personalized Oncology”, which will start at ACH in the coming fall semester. The iclusion of the subject
The inclusion of the subject in the curriculum took into account an innovative approach of patient-tailored treatment. Dr. Nele Geßler, Associate Dean for Research Affairs at ACH, Head of the Institute for Clinical Research (IKF) at Semmelweis University Hamburg Campus, and Dr. Monika Grimm, ACH Education Coordinator, presented how students are involved in and supported by tumour research activities at ACH. Two ACH students presented the ESMO Student Academy 2022 in Valencia, which they attended as scholarship holders. Another lecturers from Semmelweis University, Budapest, Dr. Zsófia Dóra Drobni, held a presentation on the role of immune checkpoint inhibitors in cardio-oncology.
Gallery
Today’s students – potential oncologists of the future
Dr. Sara Sheikhzadeh, Chief Medical Officer of Asklepios and Asklepios Medical School GmbH, moderated the session “Research and Education at ACH” and wished the young researchers presenting their work good luck. Dr. Dirk Arnold, Chief Medical Officer, Dr. Nele Geßler, Chief Medical Officer and Associate Dean for Research Affairs at ACH, and Dr. Claas Wesseler, Chief Medical Officer, selected the four students who presented their work at the ACH meeting.
The first place was awarded to Darja Sadeghi for her paper entitled “Odds of cure and long-term survival after radiofrequency ablation of colorectal liver metastases: 20 years of experience from own patient database”. The ACH graduate student was delighted with the award and the opportunity, as she said, “to present her work, in which she has invested so much time and energy, to an academic audience.” “It was a great experience for me to be able to contribute to the effectiveness of cancer research through the thesis I was required to write during my studies and thus, I hope, to the best possible treatment of patients,” she added.
ACH graduate student Francis Maren Konermann impressed the jury with her thesis “High in-hospital mortality in patients with active cancer infected with SARS-CoV-2 during the omicron phase of the pandemic – Insights from the CORONA Germany Study”, which won second place. Third place went to Larissa Maria Gessner and Nils Philipp Hofmann for their outstanding performance. The winners also received book vouchers.
Judit Szlovák
Translated by Rita Kónya
Photos by Asklepios Campus Hamburg
